Multidisciplinary Management of Patients with Psoriatic Arthritis: The Role of the Dermatologist and the Rheumatologist
Abstract
Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory disease of the musculoskeletal system that develops in 20–30% of patients with psoriasis. The condition lies at the intersection of two specialties—dermatology and rheumatology—which often leads to diagnostic delays averaging 6–7 years. Late diagnosis and delayed initiation of pathogenetic therapy are associated with irreversible joint destruction, functional impairment, and a significant reduction in patients’ quality of life.
References
1. Ogdie A., Weiss P. The epidemiology of psoriatic disease // Rheum Dis Clin N Am. — 2015. — Vol. 41. — P. 545–568.
2. Boehncke W.H., Schön M.P. Psoriasis // Lancet. — 2015. — Vol. 386. — P. 983–994.
3. Mehta N.N. et al. Attributable risk estimate of severe psoriasis on major cardiovascular events // Am J Med. — 2011. — Vol. 124. — P. 775–782.
4. Abuabara K. et al. Cause-specific mortality in patients with severe psoriasis // J Invest Dermatol. — 2010. — Vol. 130. — P. 2590–2597.
5. Gelfand J.M. et al. Risk of myocardial infarction in patients with psoriasis // JAMA. — 2006. — Vol. 296. — P. 1735–1741.
6. Armstrong E.J., Harskamp C.T., Armstrong A.W. Psoriasis and major adverse cardiovascular events // Am Heart J. — 2013. — Vol. 165. — P. 622–632.
7. Piérard G.E. et al. Psoriasis: keratinocyte immunology // J Invest Dermatol. — 2010. — P. 12–18.
8. Gottlieb A.B. et al. Psoriasis — opportunities for better patient management // Eur J Dermatol. — 2010. — Vol. 20. — P. 699–706.
9. Grundy S.M. et al. 2018 ACC/AHA guideline on management of blood cholesterol // J Am Coll Cardiol. — 2019. — Vol. 73. — P. 3168–3209.
10. Sommer D.M. et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis // Arch Dermatol Res. — 2006. — Vol. 298. — P. 321–328.
11. Zhu K.J. et al. The relationship between psoriasis and smoking // J Dermatol. — 2012. — Vol. 39. — P. 301–306.
12. Wu J.J. et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases // Arch Dermatol. — 2012. — Vol. 148. — P. 423–432.
13. Prodanovich S. et al. Methotrexate reduces incidence of vascular diseases in veterans // J Am Acad Dermatol. — 2005. — Vol. 52. — P. 262–267.
14. Ahlehoff O. et al. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis // J Intern Med. — 2013. — Vol. 273. — P. 197–204.
15. Radtke M.A. et al. Comorbidities and quality of life in psoriasis patients // JDDG. — 2011. — Vol. 9. — P. 442–450.
